A breakout could be in the cards for this biopharmaceutical play, says Carter Worth
Shares of Incyte are now moving out of a seven-month range.
Original Source
Read the full article at Cnbc →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.